Apogee Enterprises Reports Fiscal 2021 First Quarter Results
-
Significant COVID-19 related headwinds impact first-quarter results, with revenue down 19 percent from the prior year to
$289 million -
First quarter earnings of
$0.11 per diluted share and adjusted EPS of$0.15 per diluted share, with the impact of reduced revenue being mitigated by actions to manage costs and capacity - Effective working capital management drives strong cash flow, well above prior-year level
-
New project wins in Architectural Services grow segment backlog to record
$685 million - Strong market position and financial condition provide confidence in long-term outlook
“We navigated our way through a very challenging quarter, with several significant COVID-19 related headwinds across our business,” said
Consolidated results
First-quarter revenue was
Segment Results
Architectural Framing Systems
Architectural Framing Systems first-quarter revenue was
Architectural Glass
Architectural Glass revenue in the first quarter was
Architectural Services
Architectural Services revenue was
Large-Scale Optical
Large-Scale Optical revenue was
Financial Condition
Net cash provided by operating activities in the first quarter was
During the quarter, the company reduced its total debt by
Conference Call Information
The company will host a conference call today at
About
Use of Non-GAAP Financial Measures
This release and other financial communications may contain the following non-GAAP measures:
- Adjusted operating income, adjusted operating margin, adjusted net earnings and adjusted earnings per diluted share (“adjusted earnings per share” or “adjusted EPS”) are used by the company to provide meaningful supplemental information about its operating performance by excluding amounts that are not considered part of core operating results to enhance comparability of results from period to period. Examples of items excluded to arrive at this adjusted measure include: the impact of acquisition-related costs, amortization of short-lived acquired intangibles associated with backlog, restructuring costs, non-cash goodwill and other intangible impairment costs, acquired project-related charges, and COVID-19 related expenditures.
-
Backlog represents the dollar amount of signed contracts or firm orders, generally as a result of a competitive bidding process, which is expected to be recognized as revenue. Backlog is not a term defined under
U.S. GAAP and is not a measure of contract profitability. Backlog should not be used as the sole indicator of future segment revenue because we have a substantial amount of projects with short lead times that book-and-bill within the same reporting period and are not included in backlog. Free cash flow is defined as net cash provided by operating activities, minus capital expenditures. The company considers this measure an indication of its financial strength. - Adjusted EBITDA is equal to the sum of adjusted operating income depreciation and amortization expenses. We believe this metric provides useful information to investors and analysts about the Company's performance because it eliminates the effects of period-to-period changes in taxes, interest expense, and costs associated with capital investments and acquired companies.
Management uses these non-GAAP measures to evaluate the company’s historical and prospective financial performance, measure operational profitability on a consistent basis, and provide enhanced transparency to the investment community. These non-GAAP measures should be viewed in addition to, and not as a substitute for, the reported financial results of the company prepared in accordance with GAAP. Other companies may calculate these measures differently, limiting the usefulness of the measures for comparison with other companies.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements reflect Apogee management’s expectations or beliefs as of the date of this release. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. All forward-looking statements are qualified by factors that may affect the operating results of the company, including the following: (A) potential continuing negative impacts from pandemic health issues, such as the coronavirus / COVID-19, along with the impact of government stay-at-home orders or other similar directives on our future financial results of operations, our future financial condition, and our ability to continue business activities in affected regions; (B) global economic conditions and the cyclical nature of the North American and Latin American commercial construction industries, which impact our three architectural segments, and consumer confidence and the conditions of the
(1) Adjusted earnings and adjusted earnings per share are non-GAAP financial measures. See Use and Reconciliation of Non-GAAP Financial Measures in this press release for more information and a reconciliation of non-GAAP financial measures to the most directly comparable GAAP measures.
|
|||||||||||
Consolidated Condensed Statements of Income |
|||||||||||
(Unaudited) |
|||||||||||
|
|
|
|
|
|
|
|||||
|
|
Thirteen |
|
Thirteen |
|
|
|||||
|
|
Weeks Ended |
|
Weeks Ended |
|
|
|||||
(In thousands, except per share amounts) |
|
|
|
|
|
% Change |
|||||
Net sales |
|
$ |
289,095 |
|
|
$ |
355,365 |
|
|
(19) |
% |
Cost of sales |
|
228,844 |
|
|
274,398 |
|
|
(17) |
% |
||
Gross profit |
|
60,251 |
|
|
80,967 |
|
|
(26) |
% |
||
Selling, general and administrative expenses |
|
53,782 |
|
|
57,926 |
|
|
(7) |
% |
||
Operating income |
|
6,469 |
|
|
23,041 |
|
|
(72) |
% |
||
Interest and other expense, net |
|
2,463 |
|
|
2,611 |
|
|
(6) |
% |
||
Earnings before income taxes |
|
4,006 |
|
|
20,430 |
|
|
(80) |
% |
||
Income tax expense |
|
1,130 |
|
|
4,987 |
|
|
(77) |
% |
||
Net earnings |
|
$ |
2,876 |
|
|
$ |
15,443 |
|
|
(81) |
% |
|
|
|
|
|
|
|
|||||
Earnings per share - basic |
|
$ |
0.11 |
|
|
$ |
0.58 |
|
|
(81) |
% |
Average common shares outstanding |
|
26,168 |
|
|
26,597 |
|
|
(2) |
% |
||
Earnings per share - diluted |
|
$ |
0.11 |
|
|
$ |
0.58 |
|
|
(81) |
% |
Average common and common equivalent shares outstanding |
|
26,418 |
|
|
26,843 |
|
|
(2) |
% |
||
Cash dividends per common share |
|
$ |
0.1875 |
|
|
$ |
0.1750 |
|
|
7 |
% |
|
|
|
|
|
|
|
|||||
Business Segment Information |
|||||||||||
(Unaudited) |
|||||||||||
|
|
Thirteen |
|
Thirteen |
|
|
|||||
|
|
Weeks Ended |
|
Weeks Ended |
|
|
|||||
(In thousands) |
|
|
|
|
|
% Change |
|||||
Sales |
|
|
|
|
|
|
|||||
Architectural Framing Systems |
|
$ |
150,164 |
|
|
$ |
180,522 |
|
|
(17) |
% |
Architectural Glass |
|
76,911 |
|
|
100,291 |
|
|
(23) |
% |
||
Architectural Services |
|
63,551 |
|
|
65,147 |
|
|
(2) |
% |
||
Large-Scale Optical |
|
6,312 |
|
|
21,259 |
|
|
(70) |
% |
||
Eliminations |
|
(7,843 |
) |
|
(11,854 |
) |
|
(34) |
% |
||
Total |
|
$ |
289,095 |
|
|
$ |
355,365 |
|
|
(19) |
% |
Operating income (loss) |
|
|
|
|
|
|
|||||
Architectural Framing Systems |
|
$ |
7,296 |
|
|
$ |
12,273 |
|
|
(41) |
% |
Architectural Glass |
|
(494 |
) |
|
6,399 |
|
|
N/M |
|
||
Architectural Services |
|
5,343 |
|
|
4,573 |
|
|
17 |
% |
||
Large-Scale Optical |
|
(3,132 |
) |
|
4,177 |
|
|
N/M |
|
||
Corporate and other |
|
(2,544 |
) |
|
(4,381 |
) |
|
(42) |
% |
||
Total |
|
$ |
6,469 |
|
|
$ |
23,041 |
|
|
(72) |
% |
|
||||||||
Consolidated Condensed Balance Sheets |
||||||||
(Unaudited) |
||||||||
(In thousands) |
|
|
|
|
||||
Assets |
|
|
|
|
||||
Current assets |
|
$ |
330,693 |
|
|
$ |
381,910 |
|
Net property, plant and equipment |
|
320,073 |
|
|
324,386 |
|
||
Other assets |
|
420,858 |
|
|
422,695 |
|
||
Total assets |
|
$ |
1,071,624 |
|
|
$ |
1,128,991 |
|
Liabilities and shareholders' equity |
|
|
|
|
||||
Current liabilities |
|
$ |
224,130 |
|
|
$ |
271,457 |
|
Current debt |
|
155,400 |
|
|
5,400 |
|
||
Long-term debt |
|
55,500 |
|
|
212,500 |
|
||
Other liabilities |
|
132,450 |
|
|
122,856 |
|
||
Shareholders' equity |
|
504,144 |
|
|
516,778 |
|
||
Total liabilities and shareholders' equity |
|
$ |
1,071,624 |
|
|
$ |
1,128,991 |
|
Consolidated Statement of Cash Flows |
||||||||
(Unaudited) |
||||||||
|
|
Thirteen |
|
Thirteen |
||||
|
|
Weeks Ended |
|
Weeks Ended |
||||
(In thousands) |
|
|
|
|
||||
Net earnings |
|
$ |
2,876 |
|
|
$ |
15,443 |
|
Depreciation and amortization |
|
12,540 |
|
|
11,102 |
|
||
Share-based compensation |
|
1,406 |
|
|
1,618 |
|
||
Other, net |
|
3,246 |
|
|
7,578 |
|
||
Changes in operating assets and liabilities |
|
|
|
|
||||
Receivables |
|
39,650 |
|
|
(16,982 |
) |
||
Inventories |
|
(4,700 |
) |
|
835 |
|
||
Costs and earnings on contracts in excess of billings |
|
7,558 |
|
|
(6,007 |
) |
||
Accounts payable and accrued expenses |
|
(22,334 |
) |
|
(15,317 |
) |
||
Billings in excess of costs and earnings on uncompleted contracts |
|
(17,181 |
) |
|
(1,198 |
) |
||
Refundable and accrued income taxes |
|
2,847 |
|
|
(4,369 |
) |
||
Operating lease liability |
|
(2,781 |
) |
|
(1,517 |
) |
||
Other, net |
|
849 |
|
|
(928 |
) |
||
Net cash provided (used) by operating activities |
|
23,976 |
|
|
(9,742 |
) |
||
Capital expenditures |
|
(8,606 |
) |
|
(11,198 |
) |
||
Other, net |
|
(1,082 |
) |
|
(824 |
) |
||
Net cash used by investing activities |
|
(9,688 |
) |
|
(12,022 |
) |
||
(Payments) borrowings on line of credit |
|
(7,000 |
) |
|
47,500 |
|
||
Repurchase and retirement of common stock |
|
(4,731 |
) |
|
(20,010 |
) |
||
Dividends paid |
|
(4,872 |
) |
|
(4,598 |
) |
||
Other, net |
|
(731 |
) |
|
(1,270 |
) |
||
Net cash (used) provided by financing activities |
|
(17,334 |
) |
|
21,622 |
|
||
Decrease in cash and cash equivalents |
|
(3,046 |
) |
|
(142 |
) |
||
Effect of exchange rates on cash |
|
(270 |
) |
|
(143 |
) |
||
Cash, cash equivalents and restricted cash at beginning of year |
|
14,952 |
|
|
29,241 |
|
||
Cash, cash equivalents and restricted cash at end of year |
|
$ |
11,636 |
|
|
$ |
28,956 |
|
|
||||||||||||||||||
Reconciliation of Non-GAAP Financial Measures |
||||||||||||||||||
(Unaudited) |
||||||||||||||||||
Adjusted Net Earnings and Adjusted Earnings per Diluted Common Share |
||||||||||||||||||
|
|
Thirteen |
|
Thirteen |
||||||||||||||
|
|
Weeks Ended |
|
Weeks Ended |
||||||||||||||
(In thousands) |
|
|
|
|
||||||||||||||
Net earnings |
|
$ |
2,876 |
|
|
$ |
15,443 |
|
||||||||||
COVID-19 (1) |
|
1,380 |
|
|
— |
|
||||||||||||
Income tax impact on above adjustment |
|
(389 |
) |
|
— |
|
||||||||||||
Adjusted net earnings |
|
$ |
3,867 |
|
|
$ |
15,443 |
|
||||||||||
|
|
|
|
|
||||||||||||||
|
|
Thirteen |
|
Thirteen |
||||||||||||||
|
|
Weeks Ended |
|
Weeks Ended |
||||||||||||||
|
|
|
|
|
||||||||||||||
Earnings per diluted common share |
|
$ |
0.11 |
|
|
$ |
0.58 |
|
||||||||||
COVID-19 (1) |
|
0.05 |
|
|
— |
|
||||||||||||
Income tax impact on above adjustment |
|
(0.01 |
) |
|
— |
|
||||||||||||
Adjusted earnings per diluted common share |
|
$ |
0.15 |
|
|
$ |
0.58 |
|
||||||||||
|
|
|
|
|
||||||||||||||
(1) Adjustment for COVID-19-related costs, primarily incremental labor costs due to quarantine-related absenteeism and personal protective equipment for employees. |
Adjusted Operating Income and Adjusted Operating Margin |
|||||||||||
|
|
|
|||||||||
|
|
Thirteen Weeks Ended |
|||||||||
|
|
Corporate |
|
Consolidated |
|||||||
(In thousands) |
|
Operating loss |
|
Operating income |
|
Operating
|
|||||
Operating (loss) income |
|
$ |
(2,544 |
) |
|
$ |
6,469 |
|
|
2.2 |
% |
COVID-19 (1) |
|
1,380 |
|
|
1,380 |
|
|
0.5 |
% |
||
Adjusted operating (loss) income |
|
$ |
(1,164 |
) |
|
$ |
7,849 |
|
|
2.7 |
% |
|
|
|
|
|
|
|
|||||
|
|
Thirteen Weeks Ended |
|||||||||
|
|
Corporate |
|
Consolidated |
|||||||
(In thousands) |
|
Operating loss |
|
Operating income |
|
Operating
|
|||||
Operating (loss) income |
|
$ |
(4,381 |
) |
|
$ |
23,041 |
|
|
6.5 |
% |
|
|
|
|
|
|
|
|||||
(1) Adjustment for COVID-19-related costs, primarily incremental labor costs due to quarantine-related absenteeism and personal protective equipment for employees. |
EBITDA and Adjusted EBITDA |
||||||||
|
|
Thirteen |
|
Thirteen |
||||
|
|
Weeks Ended |
|
Weeks Ended |
||||
(In thousands) |
|
|
|
|
||||
Net earnings |
|
$ |
2,876 |
|
|
$ |
15,443 |
|
Income tax expense |
|
1,130 |
|
|
4,987 |
|
||
Interest and other expense, net |
|
2,463 |
|
|
2,611 |
|
||
Depreciation and amortization |
|
12,540 |
|
|
11,102 |
|
||
EBITDA |
|
$ |
19,009 |
|
|
$ |
34,143 |
|
COVID-19 (1) |
|
1,380 |
|
|
— |
|
||
Adjusted EBITDA |
|
$ |
20,389 |
|
|
$ |
34,143 |
|
|
|
|
|
|
||||
(1) Adjustment for COVID-19-related costs, primarily incremental labor costs due to quarantine-related absenteeism and personal protective equipment for employees. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200626005060/en/
Vice President, Investor Relations
952.487.7538
ir@apog.com
Source: